Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 2/2009

01-04-2009 | Original Article

Clinical efficacy of oral administration of 200 mg gatifloxacin once daily for 3 days for the treatment of patients with uncomplicated cystitis

Authors: Shingo Yamamoto, Kikuo Akiyama, Tetsuro Yoshimoto, Mototsugu Kanokogi, Hidenori Yabumoto, Hideari Ihara, Eiji Ishikawa, Masaru Yoshioka, Koji Kokura, Hiroki Shima

Published in: Journal of Infection and Chemotherapy | Issue 2/2009

Login to get access
Metadata
Title
Clinical efficacy of oral administration of 200 mg gatifloxacin once daily for 3 days for the treatment of patients with uncomplicated cystitis
Authors
Shingo Yamamoto
Kikuo Akiyama
Tetsuro Yoshimoto
Mototsugu Kanokogi
Hidenori Yabumoto
Hideari Ihara
Eiji Ishikawa
Masaru Yoshioka
Koji Kokura
Hiroki Shima
Publication date
01-04-2009
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 2/2009
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-009-0671-2

Other articles of this Issue 2/2009

Journal of Infection and Chemotherapy 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine